GenEmbryomics Limited (XGEN)

GenEmbryomics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023
Cash & Equivalents	0.04	0.1
Cash & Cash Equivalents	0.04	0.1
Cash Growth	-59.79%	-
Receivables	0.05	0.01
Other Current Assets	0.05	0.03
Total Current Assets	0.14	0.15
Property, Plant & Equipment	0	-
Total Long-Term Assets	0	0
Total Assets	0.14	0.15
Accounts Payable	0.38	0.11
Current Debt	0.71	-
Other Current Liabilities	0.01	0
Total Current Liabilities	1.1	0.12
Long-Term Debt	-	0.27
Other Long-Term Liabilities	0	0
Total Long-Term Liabilities	0	0.27
Total Liabilities	1.1	0.38
Total Debt	0.71	0.27
Debt Growth	168.05%	-
Comprehensive Income	-2.73	-0.75
Shareholders' Equity	-0.96	-0.23
Net Cash / Debt	-0.67	-0.16
Working Capital	-0.96	0.03

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).